-
Baiyunshan "domestic Viagra" Jinge will also develop the traditional Chinese medicine "Viagra" for the first time
Time of Update: 2014-09-18
It is understood that ED is one of the four most common diseases in male reproductive system The incidence rate of ED in men over 40 years old is about 46%, incidence rate is about 127 million In the
-
Tianjin's first medical technology transfer organization was established
Time of Update: 2014-09-17
Recently, Tianjin tipr-huya-aim was founded in Tianjin future science and Technology City, becoming the first professional medical technology transfer organization in the city The center will promote
-
Hualan biological Herceptin monoclonal antibody clinical application accepted
Time of Update: 2014-09-15
。 Trastuzumab was originally developed by Roche, and its trade name is Herceptin It is used to treat breast cancer and metastatic breast cancer The price of a 440mg preparation is as high as 23000 yu
-
Carbalastine bitartrate, a new Alzheimer's drug of Huahai pharmaceutical, has obtained clinical approval
Time of Update: 2014-09-15
According to the public information, carbalatin bitartrate is an acetylcholinesterase inhibitor, which is the mainstream drug for the treatment of Alzheimer's disease The original manufacturer is Nova
-
Zhongsheng pharmaceutical compound Xueshuantong capsule obtained clinical approval for increasing function
Time of Update: 2014-09-13
As a private pharmaceutical enterprise dominated by traditional Chinese medicine, Zhongsheng pharmaceutical has a good growth trend in its main business and a broad market space for its core varieties
-
Research and development costs of Enhua pharmaceutical industry will increase steadily in the future
Time of Update: 2014-09-12
According to the person, R & D investment should be in line with the company's development and will be increased gradually according to the plan "If there is a variety like a new drug, we will certain
-
Enhua pharmaceutical heavy new drug remifentanil hydrochloride for injection is approved within one month
Time of Update: 2014-09-11
People from the company told DZH news that the approved production of remifentanil is a high probability event He pointed out that the company's existing plant can be used for product production, and
-
The clinical trial of indications for hand foot mouth disease of Reduning in Kangyuan Pharmaceutical Co., Ltd. has not yet achieved results
Time of Update: 2014-09-11
The source said that due to the epidemic nature of HFMD and the combination of drugs and other factors, it is difficult to collect cases At the same time, there are also cases where doctors approve th
-
Foreign media satirize domestic "Viagra" ginger: better than fake medicine
Time of Update: 2014-09-11
A Chinese pharmaceutical company has been approved by the State Food and drug administration as the first manufacturer to officially produce a domestic version of Viagra, a famous Pfizer drug for erec
-
FDA approved orexigen / Takeda weight loss drug contract
Time of Update: 2014-09-11
According to the announcement, the drug is intended for adults with a BMI of more than 30 or an BMI of more than 27 with high blood pressure, type II diabetes or high cholesterol The contract clinical
-
Huabang pharmaceutical, a skin drug, tazarotene, betamethasone cream, enters the site for inspection
Time of Update: 2014-09-11
According to the public information, tazarotene betamethasone cream is a compound preparation of tazarotene and betamethasone, which is mainly used for the treatment of psoriasis It is developed by Hu
-
FDA approval of keryx pharmaceutical iron citrate for the control of serum phosphorus level in patients with chronic kidney disease dialysis
Time of Update: 2014-09-10
On September 5, keryx biopharmaceutical announced that FDA approved the use of ferric citrate for the control of serum phosphorus levels in dialysis patients with chronic kidney disease (CKD) "It's a
-
"Ambrano", a new heavyweight drug of Haizheng pharmaceutical, is expected to be approved for market within this year
Time of Update: 2014-09-10
Ambroxol is the first McAb drug in Haizheng pharmaceutical industry, which completed phase III clinical treatment in 2011 and declared for production on July 12, 2013 In April this year, the company s
-
Small and specialized vaccine R & D team brings opportunities for capital
Time of Update: 2014-09-09
Until the exposure of 13 price pneumonia combined vaccine in 2011, the whole team of minhai biology didn't make a penny for the company, and the supporter behind it is Shenzhen Kangtai Biological Prod
-
Hudson, a subsidiary of Hainan Haiyao, independently researched and developed new compounds and obtained US patent
Time of Update: 2014-09-06
Data show that MDM2 inhibitors are a new type of MDM2 inhibitors with high affinity The new compounds reactivate protein p53 by blocking the interaction between MDM2 and p53 P53 is a precise regulator
-
CDE drug review report in August 2014
Time of Update: 2014-09-04
According to the latest statistics of dingxiangyuan insight – China Pharma data database, in August, the drug review center (CDE) of the State Food and drug administration undertook 768 new drug regis
-
Application for production of yiqitongbi capsule, a new heavyweight drug of foci pharmaceutical, was accepted
Time of Update: 2014-09-03
According to the public information, Yiqi Tongbi capsule is a kind of traditional Chinese medicine compound preparation product used to treat coronary heart disease It obtained the approval of clinica
-
CFDA issued the first birth certificate of "Viagra" in China, Baiyunshan "Jinge" got the production approval
Time of Update: 2014-09-03
Baiyunshan said that the company received the approval document for supplementary application of "sildenafil citrate" and "sildenafil citrate tablets" issued by the State Food and Drug Administration
-
Boehringer Ingelheim and Baiji Shenzhou cooperate to promote new immunotumor drugs
Time of Update: 2014-09-02
"We are pleased to have such a significant partnership with bioxcellence, a leader in the biopharmaceutical industry We believe that the cooperation is an important milestone, which is conducive to pr
-
The application for clinical acceptance of the new 3.1 antibiotic of Huabei Pharmaceutical Co., Ltd
Time of Update: 2014-09-02
The new cephalosporin complex is a macrolide antibiotic Its mechanism is novel, mainly through inhibiting RNA polymerase of bacteria, it can produce rapid anti infection (CDI) of Clostridium difficile
